Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

ofev1

Boehringer earns NICE nod for IPF drug Ofev

September 14, 2015
Sales and Marketing Boehringer Ingelheim, IPF, NICE, idiopathic pulmonary fibrosis

NICE has recommended Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis after the German firm agreed to a …

News
keytruda

NICE recommends Keytruda for advanced skin cancer

September 7, 2015
Research and Development, Sales and Marketing Merck, NICE, keytruda, skin cancer

NICE has approved Merck’s Keytruda (pembrolizumab) as a treatment for advanced skin cancer in final draft guidance for the NHS.  …

News
cml

NHS restriction of CML treatment in England criticised

August 27, 2015
Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia

Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …

News
diabetes_injection

NICE targets tight blood sugar control in new diabetes guidelines

August 27, 2015
NICE, NICE guidelines, Public Health England, Type 1 diabetes, diabetes

NICE has urged healthcare professionals to target tighter blood sugar control, in a suite of recommendation in updated guidelines on …

News

New NICE guidelines to tackle antibiotic ‘addiction’

August 18, 2015
Manufacturing and Production AMR, Antibiotics, NICE, antimicrobial resistance, guidance, infections

NICE has published guidance to help health care professionals promote and monitor the sensible use of antibiotics – and support …

News
NICE

NICE demands more evidence of Lynparza benefits

August 6, 2015
Sales and Marketing AstraZeneca, NICE, lynparza, ovarian cancer

AstraZeneca must provide a “robust estimate of the cost effectiveness” of its ovarian cancer treatment Lynparza, or risk being rejected …

News
Daklinza

NICE restricts access to new hepatitis C treatments

July 29, 2015
Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, daklinza, harvoni, hepatits C

NICE has recommended three new treatment options for hepatitis C in draft guidance – but has been criticised for excluding …

News
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015
Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …

News
Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

News
Entyvio

NICE u-turns on Entyvio for Crohn’s disease

July 10, 2015
Medical Communications, Sales and Marketing Crohn's, Crohn’s disease, Entyvio, Millenium, NICE, Takeda, funding

NICE has performed a u-turn and recommended drug treatment Entyvio for Crohn’s disease for routine NHS funding.In final draft guidance …

News

NICE asks for more evidence from dry eye treatment maker

June 24, 2015
Research and Development, Sales and Marketing Ikervis, NHS, NICE, ciclosporin, santen pharma

A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …

News

NICE reworks cancer guidance for GPs

June 23, 2015
Sales and Marketing Cancer, GPs, NICE, UK, baker, research

The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

News
Zydelig image

NICE wants more answers from Gilead on Zydelig

June 18, 2015
Sales and Marketing Gilead, MabThera, NICE, Roche, UK, brett wells, zydelig

The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance.  But the …

News
Celgene image

NICE rejects Otelza but SMC recommends it

June 11, 2015
Sales and Marketing Astellas, Celgene, NHS, NICE, SMC, Xtandi, otezla

Draft guidance issued by NICE has seen rejections for products including Celgene’s Otelza and Astellas Pharma’s Xtandi, and a call …

News
xofigo image

NICE issues guidance for two prostate cancer drugs

June 5, 2015
Sales and Marketing Bayer, Ferring, NICE, firmagon, xofigo

NICE has published draft guidance for two prostate cancer drugs, recommending a Bayer medicine but rejecting one from Ferring Pharmaceuticals. …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026